Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.
作者信息
Richardson Daniel Russell, Ellis Brian, Mehmi Inderjit, Leys Monique
机构信息
West Virginia University Eye Institute, Morgantown, WV 26506, USA.
West Virginia University Cancer Institute, Morgantown, WV 26506, USA.
出版信息
Int J Ophthalmol. 2017 Jul 18;10(7):1183-1186. doi: 10.18240/ijo.2017.07.28. eCollection 2017.
Abstract
摘要
相似文献
1
Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.纳武单抗治疗转移性黑色素瘤相关的双侧葡萄膜炎：一例报告
Int J Ophthalmol. 2017 Jul 18;10(7):1183-1186. doi: 10.18240/ijo.2017.07.28. eCollection 2017.
2
Bilateral uveitis and macular edema induced by Nivolumab: a case report.纳武单抗诱发的双侧葡萄膜炎和黄斑水肿：一例报告
BMC Ophthalmol. 2017 Dec 1;17(1):227. doi: 10.1186/s12886-017-0611-3.
3
Bilateral Uveitis and Keratitis Following Nivolumab Treatment for Metastatic Melanoma.纳武单抗治疗转移性黑色素瘤后出现双侧葡萄膜炎和角膜炎
Med Case Rep (Wilmington). 2017;3(2). doi: 10.21767/2471-8041.100044. Epub 2017 Apr 14.
4
Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.程序性细胞死亡蛋白1抑制剂纳武单抗治疗转移性黑色素瘤患者引起的葡萄膜炎
J Infect Chemother. 2017 Nov;23(11):774-777. doi: 10.1016/j.jiac.2017.04.007. Epub 2017 May 18.
5
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.纳武单抗（抗PD-1抗体）治疗转移性皮肤恶性黑色素瘤期间出现的类伏格特-小柳-原田病葡萄膜炎
Case Rep Ophthalmol. 2019 Feb 8;10(1):67-74. doi: 10.1159/000496682. eCollection 2019 Jan-Apr.
6
[Bilateral uveitis associated with nivolumab therapy].[与纳武单抗治疗相关的双侧葡萄膜炎]
J Fr Ophtalmol. 2018 Jun;41(6):536-539. doi: 10.1016/j.jfo.2017.10.009. Epub 2018 Jun 27.
7
Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report.纳武单抗诱发转移性黑色素瘤患者白癜风：一例报告
J Oncol Pharm Pract. 2017 Dec;23(8):629-634. doi: 10.1177/1078155216667636. Epub 2016 Sep 8.
8
Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report.一例携带人类白细胞抗原DR4的个体因使用伊匹单抗治疗转移性黑色素瘤而出现双侧前葡萄膜炎和单侧面神经麻痹：病例报告
J Dermatol. 2018 Jan;45(1):113-114. doi: 10.1111/1346-8138.13779. Epub 2017 Feb 22.
9
Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma.在使用纳武单抗（抗PD-1抗体）治疗转移性皮肤恶性黑色素瘤过程中出现类似伏格特-小柳-原田病的后葡萄膜炎，期间使用了维莫非尼（BRAF抑制剂）。
Clin Case Rep. 2017 Mar 31;5(5):694-700. doi: 10.1002/ccr3.911. eCollection 2017 May.
10
HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.HLA-DRB1*04:05 在两例接受纳武利尤单抗序贯治疗的晚期黑色素瘤患者中出现的与 Vogt-Koyanagi-Harada 病样葡萄膜炎。
J Dermatol. 2018 Jun;45(6):735-737. doi: 10.1111/1346-8138.14273. Epub 2018 Feb 27.
引用本文的文献
1
Vogt-Koyanagi-Harada-Like Uveitis Secondary to Pembrolizumab in Metastatic Gastric Cancer: A Case Report and Review of the Literature.帕博利珠单抗继发于转移性胃癌的类伏格特-小柳-原田葡萄膜炎：一例报告及文献复习
Case Rep Oncol. 2024 Sep 25;17(1):1071-1086. doi: 10.1159/000541133. eCollection 2024 Jan-Dec.
2
Ocular adverse events associated with immune checkpoint inhibitors, a scoping review.与免疫检查点抑制剂相关的眼部不良事件：一项范围综述
J Ophthalmic Inflamm Infect. 2023 Feb 22;13(1):5. doi: 10.1186/s12348-022-00321-2.
3
Ocular Inflammation Induced by Immune Checkpoint Inhibitors.免疫检查点抑制剂引起的眼部炎症。
J Clin Med. 2022 Aug 25;11(17):4993. doi: 10.3390/jcm11174993.
4
Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review.靶向癌症治疗及其眼部副作用：综述
J Immunother Precis Oncol. 2021 Feb 25;4(1):6-15. doi: 10.36401/JIPO-20-21. eCollection 2021 Feb.
5
Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management.免疫检查点抑制剂相关的眼部不良事件：对其机制、诊断和管理的当前认识
Int J Ophthalmol. 2022 Apr 18;15(4):646-656. doi: 10.18240/ijo.2022.04.19. eCollection 2022.
6
Immune checkpoint inhibitor associated ocular hypertension (from presumed trabeculitis).免疫检查点抑制剂相关的眼压升高（推测因小梁炎所致）
Am J Ophthalmol Case Rep. 2021 May 24;23:101125. doi: 10.1016/j.ajoc.2021.101125. eCollection 2021 Sep.
7
Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report.尼伏单抗治疗后双侧多发性浆液性视网膜脱离：一例报告。
BMC Ophthalmol. 2020 Jun 8;20(1):221. doi: 10.1186/s12886-020-01495-w.
8
Bilateral uveitis associated with nivolumab therapy for metastatic non-small cell lung cancer.与纳武单抗治疗转移性非小细胞肺癌相关的双侧葡萄膜炎。
Am J Ophthalmol Case Rep. 2020 Apr 7;18:100691. doi: 10.1016/j.ajoc.2020.100691. eCollection 2020 Jun.
9
Diagnosis and Management of Rare Immune-Related Adverse Events.罕见免疫相关不良事件的诊断与管理。
Oncologist. 2020 Jan;25(1):6-14. doi: 10.1634/theoncologist.2019-0083. Epub 2019 Nov 6.
10
Case Series of Recurring Spontaneous Closure of Macular Hole.黄斑裂孔反复自发性闭合的病例系列
Case Rep Ophthalmol Med. 2019 Jun 16;2019:2398342. doi: 10.1155/2019/2398342. eCollection 2019.
本文引用的文献
1
Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient.一例黑色素瘤患者中由纳武单抗诱发的急性前葡萄膜炎及类Vogt-小柳-原田综合征皮疹病例。
J Dermatol. 2017 Aug;44(8):975-976. doi: 10.1111/1346-8138.13612. Epub 2016 Sep 21.
2
Bilateral Anterior Uveitis Associated with Nivolumab Therapy.与纳武单抗治疗相关的双侧前葡萄膜炎
Ocul Immunol Inflamm. 2018;26(2):283-285. doi: 10.1080/09273948.2016.1215473. Epub 2016 Sep 6.
3
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma.伊匹单抗治疗转移性黑色素瘤后出现双侧视神经视网膜炎和前葡萄膜炎。
J Ophthalmic Inflamm Infect. 2016 Dec;6(1):14. doi: 10.1186/s12348-016-0082-3. Epub 2016 May 10.
4
Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma - Case Series and Review.与皮肤黑色素瘤新疗法相关的眼内炎症——病例系列与综述
Klin Monbl Augenheilkd. 2016 Apr;233(4):540-4. doi: 10.1055/s-0042-102668. Epub 2016 Apr 26.
5
A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab.一名接受帕博利珠单抗治疗的患者发生双侧葡萄膜炎和视乳头炎的病例。
Eur J Ophthalmol. 2016 Apr 12;26(3):e46-8. doi: 10.5301/ejo.5000724.
6
Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment.自身免疫性关节病和葡萄膜炎作为程序性死亡1抑制剂治疗的并发症
Arthritis Rheumatol. 2016 Feb;68(2):556-7. doi: 10.1002/art.39406.
7
Ipilimumab-Associated Retinopathy.伊匹单抗相关性视网膜病变
Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):658-60. doi: 10.3928/23258160-20150610-10.
8
Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology.免疫检查点抑制剂伊匹单抗、帕博利珠单抗和纳武利尤单抗在肿瘤学中的现状与未来发展方向
Ann Pharmacother. 2015 Aug;49(8):907-37. doi: 10.1177/1060028015586218. Epub 2015 May 19.
9
Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma.皮肤黑色素瘤接受伊匹单抗治疗期间的双侧脉络膜病变和浆液性视网膜脱离
JAMA Ophthalmol. 2015 Aug;133(8):965-7. doi: 10.1001/jamaophthalmol.2015.1128.
10
Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib.使用维莫非尼治疗的BRAF突变型皮肤黑色素瘤患者的眼部毒性。
Am J Ophthalmol. 2014 Oct;158(4):831-837.e2. doi: 10.1016/j.ajo.2014.07.003. Epub 2014 Jul 15.
Zotero 插件